ACE2 and COVID-19: Among the main theories of the increased mortality observed among patients with COVID-19 treated with ACE inhibitors and angiotensin receptor beta blockers, the intake of antihypertensive drugs was hypothesized to increase the expression of ACE2, negatively affecting the severity and evolution of the disease.